Children in the UK will be able to receive Palforzia – a life-changing oral treatment for peanut allergies – as NHS standard of care following approval for use by NICE.
The NHS has struck a deal for a life-saving treatment that will offer babies and young children with a rare and life-limiting genetic disease the prospect of a normal life.
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.
Participation in research studies is about to become easier than ever for residents across Greater Manchester thanks to the arrival of our state-of-the-art Research Van.
A national COVID-19 vaccine study is urging pregnant women across Greater Manchester to help researchers discover the most effective use of vaccines during pregnancy.
People taking part in a vaccine study at Manchester University NHS Foundation Trust (MFT) have shared their motivations for taking part – in the hope others might be inspired to do the same.